Personal profile

researchinterests

Dr. Carl Asche is currently Research Professor of Medicine and Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria. He is also currently appointed as Research Professor of Pharmacy Systems, Outcomes and Policy at the University of Illinois at Chicago College of Pharmacy. Previously he was Associate Research Professor of Pharmacotherapy, Director of Graduate Studies, and Director of Fellowships at the University of Utah College of Pharmacy. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. Carl is the author or co-author of over 75 papers in the medical literature, on the editorial boards for "Pharmacoeconomics" and "Current Medical Research and Opinion” and on the board for “Guidelines and Economists Network International” and Director of Communications for the Chicago Regional Chapter of the International Society of Pharmacoeconomics and Outcomes Research. He has held managerial positions for the Bristol-Myers Squibb Pharmaceutical Group and Aventis Pharmaceuticals where he managed health economics and outcomes research applied to both research and development and customer marketing areas in highly matrix-structured organizations. He received his PhD (Economics) from the University of Surrey and his MSc (Health Economics) from the University of York.

researchinterests

Dr. Carl Asche is currently Research Professor of Medicine and Director of the Center for Outcomes Research at the University of Illinois College of Medicine at Peoria. He is also currently appointed as Research Professor of Pharmacy Systems, Outcomes and Policy at the University of Illinois at Chicago College of Pharmacy. Previously he was Associate Research Professor of Pharmacotherapy, Director of Graduate Studies, and Director of Fellowships at the University of Utah College of Pharmacy. His research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. Carl is the author or co-author of over 75 papers in the medical literature, on the editorial boards for "Pharmacoeconomics" and "Current Medical Research and Opinion” and on the board for “Guidelines and Economists Network International” and Director of Communications for the Chicago Regional Chapter of the International Society of Pharmacoeconomics and Outcomes Research. He has held managerial positions for the Bristol-Myers Squibb Pharmaceutical Group and Aventis Pharmaceuticals where he managed health economics and outcomes research applied to both research and development and customer marketing areas in highly matrix-structured organizations. He received his PhD (Economics) from the University of Surrey and his MSc (Health Economics) from the University of York.

Keywords

  • Health Economics
  • Pharmacoeconomics
  • Outcomes Research

Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 21 Similar Profiles
Costs and Cost Analysis Medicine & Life Sciences
Economics Medicine & Life Sciences
Cost-Benefit Analysis Medicine & Life Sciences
Delivery of Health Care Medicine & Life Sciences
Health Care Costs Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
Hospitalization Medicine & Life Sciences
Pain Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2017

  • 1416 Citations
  • 21 h-Index
  • 93 Article
  • 4 Book

Allergies, antibiotics use, and multiple sclerosis

Ren, J., Ni, H., Kim, M., Cooley, K. L., Valenzuela, R. M. & Asche, C. V. Aug 3 2017 In : Current Medical Research and Opinion. 33, 8, p. 1451-1456 6 p.

Research output: Contribution to journalArticle

Multiple Sclerosis
Anti-Bacterial Agents
International Classification of Diseases
Penicillins
Respiratory System
Betamethasone
Budgets
Standard of Care
Psoriasis
Health Care Costs
3 Citations

Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis

Yuan, F., Ni, H., Asche, C. V., Kim, M., Walayat, S. & Ren, J. Mar 6 2017 In : Current Medical Research and Opinion. p. 1-7 7 p.

Research output: Contribution to journalArticle

Bifidobacterium
Irritable Bowel Syndrome
Meta-Analysis
Probiotics
Abdominal Pain

Evaluation of Healthcare Interventions and Big Data: Review of Associated Data Issues

Asche, C. V., Seal, B., Kahler, K. H., Oehrlein, E. M. & Baumgartner, M. G. May 4 2017 In : PharmacoEconomics. p. 1-7 7 p.

Research output: Contribution to journalArticle

Delivery of Health Care
Computer Security
Ownership
Clinical Coding
Costs and Cost Analysis
2 Citations

Local infiltration for postsurgical analgesia following total hip arthroplasty: a comparison of liposomal bupivacaine to traditional bupivacaine

Asche, C. V., Ren, J., Kim, M., Gordon, K., McWhirter, M., Kirkness, C. S. & Maurer, B. T. Jul 3 2017 In : Current Medical Research and Opinion. 33, 7, p. 1283-1290 8 p.

Research output: Contribution to journalArticle

Bupivacaine
Arthroplasty
Analgesia
Hip
Ketorolac

Prizes

Chinoin Young Investigator Award

Carl V. Asche (Recipient), 1997

Prize: Prize (including medals and awards)

Nobuo Maeda International Research Award

Carl V. Asche (Recipient), 1996

Prize: Prize (including medals and awards)

Nobuo Maeda International Research Award

Carl V. Asche (Recipient), 1997

Prize: Prize (including medals and awards)

North American Medical Affairs Leadership Team Award

Carl V. Asche (Recipient), 2003

Prize: Prize (including medals and awards)